Evidence map›Paper›PMID 26762269›Full record

ArticleCardiovascular research2016

TBX5 mutations contribute to early-onset atrial fibrillation in Chinese and Caucasians.

Ji-Fang Ma, Fan Yang, Saagar N Mahida, Ling Zhao, Xiaomin Chen, Michael L Zhang, Zhijun Sun, Yan Yao, Yi-Xin Zhang, Gu-Yan Zheng and 11 more

Open access · bronzeAbstract read
In one paragraph

Article in Cardiovascular research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 49 citations in OpenAlex.

  1. NovelBiomedicines · 2026
    Article
  2. THSD7A Exacerbates Atherosclerosis via Activation of Signaling Axis αvβ3/CEBPD/IL1A.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Rare TruncatingGenes · 2026
    Article
  4. Article
  5. Gene Therapy for Inherited Cardiac Arrhythmias.Journal of cardiovascular translational research · 2025
    Review
  6. Article
  7. Animal and cellular models of atrial fibrillation: a review.Frontiers in cardiovascular medicine · 2025
    Review
  8. Genetics, transcriptomics, metagenomics, and metabolomics in the pathogenesis and prediction of atrial fibrillation.European heart journal supplements : journal of the European Society of Cardiology · 2024
    Article
  9. Discovery ofBiology · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Molecular medicine reports · 2022
    Article
  14. Review
  15. Review
  16. Article
  17. Inward Rectifier KJournal of the American Heart Association · 2020
    Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 8 institutions in 2 countries.

Ji-Fang MaDepartment of Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
Fan YangDepartment of Human Population Genetics and Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine (IMM), Peking University, 5 Yiheyuan Rd., Beijing 100871, China.
Saagar N MahidaCardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA.
Ling ZhaoDepartment of Human Population Genetics and Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine (IMM), Peking University, 5 Yiheyuan Rd., Beijing 100871, China.
Xiaomin ChenKey Laboratory of Ningbo First Hospital and Cardiovascular Center of Ningbo First Hospital, Ningbo University, 59 Liuting St., Ningbo 315010, China.
Michael L ZhangCardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA.
Zhijun SunCardiovascular Department, PLA General Hospital, 28 Fuxing Rd, Beijing 100853, China.
Yan YaoDepartment of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, China.
Yi-Xin ZhangDepartment of Human Population Genetics and Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine (IMM), Peking University, 5 Yiheyuan Rd., Beijing 100871, China.
Gu-Yan ZhengDepartment of Human Population Genetics and Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine (IMM), Peking University, 5 Yiheyuan Rd., Beijing 100871, China.
Jie DongDepartment of Human Population Genetics and Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine (IMM), Peking University, 5 Yiheyuan Rd., Beijing 100871, China.
Ming-Jun FengKey Laboratory of Ningbo First Hospital and Cardiovascular Center of Ningbo First Hospital, Ningbo University, 59 Liuting St., Ningbo 315010, China.
Rui ZhangDepartment of Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
Jian SunDepartment of Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
Shuo LiDepartment of Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
Qun-Shan WangDepartment of Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China.
Huiqing CaoDepartment of Human Population Genetics and Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine (IMM), Peking University, 5 Yiheyuan Rd., Beijing 100871, China.
Emelia J BenjaminDepartment of Epidemiology, Boston University School of Public Health, Boston, MA, USA National Heart, Lung, and Blood Institute's and Boston University's Framingham Heart Study, Framingham, MA, USA Preventive Medicine Section, Department of Medicine, Boston University School of Medicine, Boston, MA, USA Cardiology Section, Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
Patrick T EllinorCardiovascular Research Center, Massachusetts General Hospital, Charlestown, MA, USA Cardiac Arrhythmia Service, Massachusetts General Hospital, Boston, MA, USA.
Yi-Gang LiDepartment of Cardiology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China tianxiaoli@pku.edu.cn drliyigang@outlook.com.
Xiao-Li TianDepartment of Human Population Genetics and Beijing Key Laboratory of Cardiometabolic Molecular Medicine, Institute of Molecular Medicine (IMM), Peking University, 5 Yiheyuan Rd., Beijing 100871, China tianxiaoli@pku.edu.cn drliyigang@outlook.com.
Peking University · CNShanghai Jiao Tong University · CNMassachusetts General Hospital · USNingbo University · CNXinHua Hospital · CNCapital Medical University · CNChinese PLA General Hospital · CNNational Heart Lung and Blood Institute · US

Funding

IDENTIFICATION OF COMMON GENETIC VARIANTS FOR ATRIAL FIBRILLATION AND PR INTERVALR01HL092577 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI BENJAMIN, EMELIA J., ELLINOR, PATRICK THOMAS · 2009 to 2025
$20.6M
Determining the Role of the Potassium Channel, KCNN3, in Atrial FibrillationR01HL104156 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ELLINOR, PATRICK THOMAS · 2010 to 2013
$2.1M
Mentoring in Arrhythmia ResearchK24HL105780 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI ELLINOR, PATRICK THOMAS · 2011 to 2020
$1.2M
NHLBI NIH HHS 1K24HL105780NHLBI NIH HHS 1R01HL092577NHLBI NIH HHS 1R01HL104156NHLBI NIH HHS R01 HL092577NHLBI NIH HHS R01 HL104156
6 · The paper itself

Abstract

aimsAtrial fibrillation (AF) is a common arrhythmia with an important heritable aspect. The genetic factors underlying AF have not been fully elucidated. METHODS AND

resultsWe screened six candidate genes (CAV1, KCNJ2, KCNQ1, NKX2.5, PITX2, and TBX5) for novel mutations in 139 patients of Chinese descent with early-onset AF and 576 controls. Four missense TBX5 mutations, p.R355C, p.Q376R, p.A428S, and p.S372L, were identified in evolutionarily conserved regions. We did not find any mutations in CAV1, KCNJ2, KCNQ1, NKX2.5, and PITX2. These mutations increased the expression of atrial natriuretic peptide (ANP) and connexin-40 (CX40) in the primarily cultured rat atrial myocytes but did not alter the expression of cardiac structural genes, atrial myosin heavy chain-α (MHC-α) and myosin light chain-2α (MLC-2α). Overexpression of p.R355C developed an atrial arrhythmia suggestive of paroxysmal AF in the zebrafish model. To replicate our findings, we screened TBX5 in 527 early-onset AF cases from the Massachusetts General Hospital AF study. A novel TBX5 deletion (ΔAsp118, p.D118del) was identified, while no TBX5 mutations were identified in 1176 control subjects.

conclusionOur results provide both genetic and functional evidence to support the contribution of TBX5 gene in the pathogenesis of AF. The potential mechanism of arrhythmia may be due in part to the disturbed expression of ANP and CX40.

Indexed as

Genetic Predisposition to DiseaseAdultAgedAge of OnsetAsian PeopleAtrial FibrillationConnexinsFemaleGap Junction alpha-5 ProteinHomeodomain ProteinsHumansMiddle AgedMutationMutation, MissensePregnancyT-Box Domain ProteinsConnexinsGap Junction alpha-5 ProteinHomeodomain ProteinsT-Box Domain ProteinsT-box transcription factor 5Transcription FactorsANPAtrial fibrillationConnexinMutationTBX5

Identifiers

PMID26762269
PMCPMC4752043
OpenAlexW2271087743

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.